CellWell record HH-1751
Screening for Lung Cancer Has Limited Effectiveness Globally and Distracts from Much Needed Efforts to Reduce the Critical Worldwide Prevalence of Smoking and Related Morbidity and Mortality
C. Verghese et al
J. Global Oncology 4 ( ยท 2018
In plain language
In a perspective article, the authors argue low-dose CT lung cancer screening shows limited real-world benefit, especially in lower-income countries, and that smoking-reduction efforts offer a more cost-effective way to cut lung cancer deaths.
- Design
- Clinical trial
- Studied in
- Human
Cite this record: https://thecellwell.org/studies/HH-1751
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.